– USA, CT – Quantum-Si Incorporated (Nasdaq: QSI), The Protein Sequencing Company, today announced the appointment of Paula Dowdy to its Board of Directors.
About Paula Dowdy
Paula Dowdy serves on the Board of Directors for SPT Labtech, a world-leading lab automation tools company based in the UK, and is an advisor at EQT Life Sciences, one of Europe’s leading investors targeting innovative life sciences and healthcare. Previously, she was the SVP and General Manager of Europe, Middle East, and Africa at Illumina where she led the region through a period of significant growth. Before Illumina, Paula Dowdy spent over 20 years at Cisco Systems, Inc., and held various positions in products, services, and software in the United States, and globally.
Throughout her career, Paula Dowdy has demonstrated a commitment to supporting companies as they scale and helping them achieve record revenue growth. Her expertise in commercial strategy, market development, and global operations will be instrumental as Quantum-Si continues to expand its reach and impact in proteomics.
Paula Dowdy earned an MBA from Pepperdine University and a Bachelor of Arts degree from the University of California, Berkeley. Her appointment to the Quantum-Si Board of Directors is effective as of today.
About Quantum-Si Incorporated
Quantum-Si, The Protein Sequencing Company, is focused on revolutionizing the growing field of proteomics. The Company’s suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable next-generation single-molecule protein sequencing and digitize proteomic research to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing.
For more information: https://www.quantum-si.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.